跳至主要内容
临床试验/CTRI/2020/03/023767
CTRI/2020/03/023767招募中4 期

Effect of Ivabradine on Exercise Capacity and Plasma NT-proBNP levels in Patients with Dilated Cardiomyopathy- A Randomized Controlled Clinical Trial

SRM College of Pharmacy0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients with dilated cardiomyopathy and normal sinus rhythm with heart rate >= 75 beats per minute and dilated cardiomyopathy of NYHA class II and III with LVEF <= 40 % at the time of screening
  • 2.Patient willing to perform six-minute walk test and donâ??t have any orthopedic limitations

排除标准

  • 1.Patient with Acute Heart Failure, Acute Myocardial Infarction, Stroke, Transient Ischemic attack and Patients who are Pacemaker Dependent
  • 2. Patient with other co-morbid disease conditions such as End Stage Renal Disease, Hepatic Impairment and Pulmonary Diseases
  • 3. Patient taking Concomitant Strong Potent CYP3A4 Inhibitors
  • 4. Pregnancy and Lactating women
  • 5. Patients who are in Treatment with non dihydropyridine CCB, C-I Anti Arrhythmic agents and QTc Interval Prolonging Medications.
  • 6. Any Known Contraindications or Hypersensitivity to Ivabradine

研究者

发起方
SRM College of Pharmacy

相似试验